These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 27484766

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial].
    Yan GY, Xu ZY, Deng HB, Wan ZY, Zhang L, Zhu JY.
    Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):525-30. PubMed ID: 21565138
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Efficacy of NO regimen and NP regimen on advanced non-small cell lung cancer: a prospective randomized trial].
    Gao JF, Zhang XH, Wang J, Rao ZG, Zhu YZ, Ou WL, Zhang BC, Du GZ.
    Ai Zheng; 2005 Aug; 24(8):990-3. PubMed ID: 16086879
    [Abstract] [Full Text] [Related]

  • 9. Has aidi injection the attenuation and synergistic efficacy to gemcitabine and cisplatin in non-small cell lung cancer? A meta-analysis of 36 randomized controlled trials.
    Xiao Z, Wang C, Chen L, Tang X, Li L, Li N, Li J, Gong Q, Tang F, Feng J, Li X.
    Oncotarget; 2017 Jan 03; 8(1):1329-1342. PubMed ID: 27901493
    [Abstract] [Full Text] [Related]

  • 10. A network meta-analysis: The best Yiqi Fuzheng Chinese herbal injections for use based on the NP regimen to treat NSCLC.
    Luo H, Zheng W, Yan Q, Wang B, Ye B, Deng S, He F, Yang X, Wang X.
    Medicine (Baltimore); 2020 Jul 31; 99(31):e20500. PubMed ID: 32756075
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [A randomized trial comparing oxaliplatin plus vinorelbine versus cisplatin plus vinorelbine for the treatment of patients with advanced non-small-cell lung cancer].
    Zhang XR, Hou M, Sun JD, Gao JF, Zhu YZ, Peng DW, Zhang YP, Chen J, Yang JL, Liang J, Wang PH, Chu DT.
    Zhonghua Zhong Liu Za Zhi; 2005 Dec 31; 27(12):743-6. PubMed ID: 16483488
    [Abstract] [Full Text] [Related]

  • 13. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
    Lena MD, Ramlau R, Hansen O, Lorusso V, Wagner L, Barni S, Cristovao MM, Huber R, Alberola V, Mitrovic M, Colin C, Gasmi J.
    Lung Cancer; 2005 Apr 31; 48(1):129-35. PubMed ID: 15777980
    [Abstract] [Full Text] [Related]

  • 14. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T, Pujol JL, Douillard JY, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S, Besson F.
    Semin Oncol; 1994 Oct 31; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [Abstract] [Full Text] [Related]

  • 15. Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.
    Westeel V, Quoix E, Moro-Sibilot D, Mercier M, Breton JL, Debieuvre D, Richard P, Haller MA, Milleron B, Herman D, Level MC, Lebas FX, Puyraveau M, Depierre A, French Thoracic Oncology Collaborative Group (GCOT).
    J Natl Cancer Inst; 2005 Apr 06; 97(7):499-506. PubMed ID: 15812075
    [Abstract] [Full Text] [Related]

  • 16. Post-operative treatment with cisplatin and vinorelbine in Chinese patients with non-small cell lung cancer: a clinical prospective analysis of 451 patients.
    Wang J, Liu F, Huang DX, Jiang B.
    Asian Pac J Cancer Prev; 2012 Apr 06; 13(9):4505-10. PubMed ID: 23167369
    [Abstract] [Full Text] [Related]

  • 17. A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naïve non-small-cell lung cancer in Taiwan.
    Chen YM, Perng RP, Shih JF, Tsai CM, Whang-Peng J.
    Lung Cancer; 2007 Jun 06; 56(3):363-9. PubMed ID: 17306906
    [Abstract] [Full Text] [Related]

  • 18. A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): paclitaxel plus carboplatin versus vinorelbine plus cisplatin.
    Chang WJ, Sun JM, Lee JY, Ahn JS, Ahn MJ, Park K.
    Lung Cancer; 2014 Apr 06; 84(1):51-5. PubMed ID: 24521819
    [Abstract] [Full Text] [Related]

  • 19. [Enhancing effect of compound Kusheng injection in combination with chemotherapy for patients with advanced non-small cell lung cancer].
    Fan CX, Lin CL, Liang L, Zhao YY, Liu J, Cui J, Yang QM, Wang YL, Zhang AR.
    Zhonghua Zhong Liu Za Zhi; 2010 Apr 06; 32(4):294-7. PubMed ID: 20510083
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin in combination with metronomic vinorelbine as front-line treatment in advanced non-small cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
    Katsaounis P, Kotsakis A, Agelaki S, Kontopodis E, Agelidou A, Kentepozidis N, Vamvakas L, Christopoulou A, Karachaliou N, Hatzidaki D, Georgoulias V.
    Cancer Chemother Pharmacol; 2015 Apr 06; 75(4):821-7. PubMed ID: 25702051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.